Invivyd develops antibody therapies to prevent and treat serious viral infections, starting with COVID-19. It last closed at $0.51 on Nov 17, down 4.67% on the day. The average 12-month price target from 2 analysts is $10.00 (+1850.8% from the last close), with a high of $10.00 and a low of $10.00.
Only 2 firms rated IVVD in the past 90 days, not enough for a consensus
Average 12-month target
$10.00
▲ 1850.8% upside
Based on 2 analysts who set a price target on IVVD in the past 90 days. The average target is $10.00, with a high of $10.00 and a low of $10.00, compared with the last close of $0.51.
Low $10.00Avg $10.00High $10.00
Blue marker: last close $0.51
Highest target$10.00
Average target$10.00
Lowest target$10.00
Latest rating changes
BTIGReiterated
Sep 14Buy$10
Cantor FitzgeraldReiterated
Aug 27Buy$10
HC Wainwright & Co.Reiterated
Jun 15Buy$10
Date
Firm
Action
Rating
Price target
Sep 14
BTIG
Reiterated
Buy
$10
Aug 27
Cantor Fitzgerald
Reiterated
Buy
$10
Jun 15
HC Wainwright & Co.
Reiterated
Buy
$10
Loading…
Technical Analysis
IVVD · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold
The stock is 15% below its 20 day and 38% below its 50 day average. It is 110% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 36), near oversold. The nearest support is the 52 week low at $0.49, and the nearest resistance the Pivot at $0.52.
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityNormal, 11.5%/day
Key levels
$3.0752 week high+502.0%
$1.07200 day average+109.8%
$0.74100 day average+45.1%
$0.7150 day average+39.2%
$0.64Swing high (Oct 29)+25.5%
$0.5920 day average+15.7%
$0.55Pivot R1+7.8%
$0.52Pivot+2.0%
$0.51Last close
$0.4952 week low−3.9%
$0.48Pivot S1−5.9%
Indicators
RSI (14)
35.68
Weak, oversold below 30
Neutral
MACD
-0.04
Below its signal line
Bearish
Stochastic
24.4
Middle of its range
Neutral
ADX (14)
19.0
No clear trend
Williams %R
-84.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-222.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−11.8%
Change over 10 sessions
Bearish
ATR (14)
$0.06
Typical daily range, 11.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityNormal, 35.7%/day
Key levels
$3.0752 week high+502.0%
$1.07200 day average+109.8%
$0.74100 day average+45.1%
$0.7150 day average+39.2%
$0.64Swing high (Oct 29)+25.5%
$0.5920 day average+15.7%
$0.55Pivot R1+7.8%
$0.52Pivot+2.0%
$0.51Last close
$0.4952 week low−3.9%
$0.48Pivot S1−5.9%
Indicators
RSI (14)
36.16
Weak, oversold below 30
Neutral
MACD
-0.17
Below its signal line
Bearish
Stochastic
5.9
Near the bottom of its range
Oversold
ADX (14)
18.0
No clear trend
Williams %R
-96.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-116.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−34.7%
Change over 10 sessions
Bearish
ATR (14)
$0.18
Typical daily range, 35.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for IVVD
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how IVVD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow IVVD usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How IVVD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IVVD is in one of them and how their past IVVD trades turned out.
Invivyd is a biopharmaceutical company based in New Haven, Connecticut, that develops antibody therapies for serious viral infectious diseases. Its first authorized product, PEMGARDA, is an antibody used to help prevent COVID-19 in people who are immunocompromised and unlikely to respond well to vaccination. The company is also developing next generation COVID-19 antibodies and early candidates for diseases such as RSV and measles. Its customers are mainly patients and the healthcare providers who treat them.